Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of lumbar spine pseudoarthrosis: a strain-based approach.

The spine journal : official journal of the North American Spine Society·2026
Same author

P-15 Peptide Enhanced Bone Graft Improves Time to Fusion in Transforaminal Lumbar Interbody Fusion: A Randomized, Controlled, Investigational Device Exemption Study.

Spine·2025
Same author

P-15 Peptide Enhanced Bone Graft in Transforaminal Lumbar Interbody Fusion: A Randomized, Controlled, Investigational Device Exemption Study Demonstrating Improved Composite Clinical Success.

Spine·2025
Same author

Titanium-Coated Polyetheretherketone Cages Versus Uncoated Polyetheretherketone Cages for Lumbar Spinal Fusion: A Systematic Review and Meta-Analysis.

Global spine journal·2025
Same author

Adverse Impact of Obesity on Lumbar Spine Fusion, Patient-reported Outcomes and Costs: A Systematic Review and Meta-analysis.

Spine·2025
Same author

Adverse Impact of Diabetes on Spine Fusion and Patient-Reported Outcomes: A Systematic Review and Meta-analysis.

Spine·2025

Related Experiment Video

Updated: May 22, 2026

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix
09:00

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix

Published on: February 9, 2015

Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration.

Suzanne Zeitouni1, Ulf Krause, Bret H Clough

  • 1Institute for Regenerative Medicine at Scott and White Hospital, Texas A&M Health Science Center, Module C, 5701 Airport Road, Temple, TX 76502, USA.

Science Translational Medicine
|May 4, 2012
PubMed
Summary
This summary is machine-generated.

Enhancing bone repair with human mesenchymal stem cells (hMSCs) requires optimizing their retention. Combining ECM scaffolds with PPARγ inhibitor-treated hMSCs achieved complete bone defect repair in mice within 3 weeks.

More Related Videos

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
06:05

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells

Published on: July 14, 2023

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

Related Experiment Videos

Last Updated: May 22, 2026

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix
09:00

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix

Published on: February 9, 2015

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
06:05

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells

Published on: July 14, 2023

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Surgery

Background:

  • Bone defect repair remains challenging due to incomplete understanding of osteogenesis and bone substitute biocompatibility.
  • Human mesenchymal stem cells (hMSCs) show potential for bone growth but exhibit variable in vivo repair efficacy.
  • hMSC-mediated bone repair may be time-dependent, potentially limited by the multistage healing process.

Purpose of the Study:

  • To investigate if hMSC osteo-repair capacity can be augmented and sustained for complete bone defect healing.
  • To develop a strategy for prolonged hMSC retention at injury sites, overcoming limitations in the bone remodeling phase.
  • To evaluate the efficacy of combining extracellular matrix (ECM) scaffolds with inhibitor-treated hMSCs for critical-sized bone defect repair.

Main Methods:

  • Utilized a mouse calvarial defect model to assess bone healing.
  • Treated hMSCs with a peroxisome proliferator-activated receptor γ (PPARγ) inhibitor to enhance osteo-repair capacity.
  • Developed an hMSC-derived extracellular matrix (ECM) scaffold to promote sustained hMSC retention.
  • Co-administered inhibitor-treated hMSCs with ECM scaffolds to evaluate repair outcomes.

Main Results:

  • PPARγ inhibitor treatment augmented hMSC osteo-repair, but efficacy was limited to the rapid osteogenic phase.
  • hMSC retention was lost during the bone remodeling phase, leading to incomplete healing.
  • Combining inhibitor-treated hMSCs with ECM scaffolds ensured prolonged retention at the injury site.
  • This combined approach resulted in reproducible and complete repair of critical-sized bone defects in mice within 3 weeks.

Conclusions:

  • hMSC-derived ECM scaffolds can facilitate extended, site-specific retention of hMSCs.
  • Optimizing hMSC treatment and delivery timing with ECM scaffolds significantly improves bone repair outcomes.
  • This strategy holds promise for substantially and reproducibly enhancing bone repair in critical-sized defects.